Indian drug and medical services startup PharmEasy has withdrawn the draft red herring prospectus (DRHP) it filed for its initial public offering (IPO) while Koye Pharmaceuticals has hired investment bank o3 Capital for a fresh fundraise.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
